Michael Perch

Dr. Michael Perch

Department of Cardiology, Section for Lung Transplantation, Copenhagen University Hospital—Rigshospitalet, 2100 Copenhagen, Denmark
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
GSGregory I. Snell
Gregory I. Snell
RYRoger D. Yusen
Roger D. Yusen
DWDavid Weill
David Weill
MSMartin Strueber
Martin Strueber
EGEdward Garrity
Edward Garrity
JCJason D. Christie
Jason D. Christie


1 September 2004 in Pediatrics
Verified
Journal Article
Closed access
PDF file
TFThea Koelsen Fischer
Thea Koelsen Fischer
KBKristine Bihrmann
Kristine Bihrmann
MPMichael Perch
Michael Perch
AKAnders Koch
Anders Koch
JWJan Wohlfahrt
Jan Wohlfahrt
MMMads Melbye
Mads Melbye
Objective. To describe incidence and temporal trends of intussusceptions in Danish children during 1980 to 2001. Methods. A population-based cohort study was conducted of 1.67 million children who were younger than 5 years during 1980 to 2001 and were followed up for 6.66 million person-years. The Danish National Patient Registry was used to identify cases of intussusception in the cohort. Age-specific incidence rates were main outcome measure. Results. A total of 1814 cases of intussusception among children who were younger than 5 years were reported from 1980 to 2001. The incidence rate remained fairly constant during 1980 to 1990 but decreased by 55% (95% confidence interval: 43%–65%) from 1990 to 2001. The reduction was most pronounced among children aged 3 to 5 months. Conclusions. The incidence of intussusception among Danish children declined significantly during the 1990s, particularly among infants 3 to 5 months of age.

6 August 2023 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
TSTajinder P. Singh
Tajinder P. Singh
WCWida S. Cherikh
Wida S. Cherikh
EHEileen Hsich
Eileen Hsich
ALAlexandra Lewis
Alexandra Lewis
MPMichael Perch
Michael Perch
RCRebecca Cogswell
Rebecca Cogswell

25 July 2022 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
EHEileen Hsich
Eileen Hsich
TSTajinder P. Singh
Tajinder P. Singh
WCWida S. Cherikh
Wida S. Cherikh
MHMichael O. Harhay
Michael O. Harhay
DHDon Hayes
Don Hayes
JSJosef Stehlik
Josef Stehlik

1 September 2002 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
TFThea Koelsen Fischer
Thea Koelsen Fischer
PVPalle Valentiner‐Branth
Palle Valentiner‐Branth
HSHans Steinsland
Hans Steinsland
MPMichael Perch
Michael Perch
GSGina Santos
Gina Santos
HSHalvor Sommerfelt
Halvor Sommerfelt
To study the natural history of rotavirus infection and to determine the protection it confers against reinfection and diarrhea, 200 newborns in Guinea-Bissau were prospectively followed for up to 2 years. Rotavirus was detected in stool specimens collected weekly. By age 2 years, the incidence of primary rotavirus infection was 74%. In the first 3 months of life, 17% of the infections were diarrhea associated, compared with 60% at 9–11 months; after age 18 months, all infections were asymptomatic. A primary infection conferred 52% (95% confidence interval [CI], 16% to 73%) and 70% (95% CI, 29% to 87%) protection against subsequent rotavirus infection and rotavirus diarrhea, respectively. The protection was 66% (95% CI, 24% to 85%) against reinfection within the same epidemic, compared with 34% (95% CI, −29% to 67%) against reinfection in any subsequent epidemic. The high level of protection against symptomatic rotavirus infection provides an important incentive for development of a rotavirus vaccine